DRD3 Antikörper (Alexa Fluor 594)
Kurzübersicht für DRD3 Antikörper (Alexa Fluor 594) (ABIN6828350)
Target
Alle DRD3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- DRD3 Conjugated Antibody
-
-
anti-Dopamine Receptor D3 (DRD3) (AA 352-446) antibody
DRD3 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D3 (DRD3) (AA 213-329) antibodyDRD3 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D3 (DRD3) (AA 15-29), (Extracellular) antibodyKO Validated DRD3 Reaktivität: Ratte WB, IHC, IF, FACS, LCI Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D3 (DRD3) (AA 213-329) antibodyDRD3 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D3 (DRD3) (Cytoplasmic Domain) antibodyDRD3 Reaktivität: Human, Maus, Hund, Pferd, Schwein, Affe, Fledermaus, Hamster IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D3 (DRD3) (C-Term) antibodyDRD3 Reaktivität: Human, Ratte, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D3 (DRD3) (AA 213-329) antibodyDRD3 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D3 (DRD3) antibodyDRD3 Reaktivität: Human WB, ELISA Wirt: Kaninchen Monoclonal 5B10 unconjugated Recombinant Antibody
anti-Dopamine Receptor D3 (DRD3) (AA 352-446) antibody (AbBy Fluor® 594)DRD3 Reaktivität: Human, Ratte, Maus WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal AbBy Fluor® 594
anti-Dopamine Receptor D3 (DRD3) (AA 1-100) antibodyDRD3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- AF594 conjugated: most apllications: 1: 50 - 1: 250
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C for 6 months.
-
-
- DRD3 (Dopamine Receptor D3 (DRD3))
-
Andere Bezeichnung
- DRD3
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Proton Transport, Negative Regulation of Transporter Activity
Target
-
